SK hynix set a new quarterly earnings record for the third quarter, powered by strong artificial intelligence (AI) chip sales ...

The MarketWatch News Department was not involved in the creation of this content. Nearly 3 in 4 patients don't report all of their seizures to their doctor, highlighting risks in treatment decisions ...

PARAMUS, N.J., Oct. 24, 2025 /PRNewswire/ -- SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., today ...

SK Group showcased its capabilities for meeting the fast-growing market demand for artificial intelligence (AI) during its ...

When SK Life Science began, it tapped into healthcare providers, patients, and scientists to ensure it was relentlessly focused on medical solutions to help drive success in treating central nervous ...

FAIR LAWN, N.J., Nov. 29, 2017 /PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative biopharmaceutical company focused on developing and bringing to ...

FAIR LAWN, N.J., Nov. 1, 2018 /PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals, Co., Ltd., focuses on developing and commercializing ...

Nearly 3 in 4 patients don't report all of their seizures to their doctor, highlighting risks in treatment decisions and life-saving conversations The survey, Hope, Hesitancy, and Hard Truths: A ...

As National Epilepsy Awareness Month begins on Saturday, new survey findings from SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK ...